He dumped his stock in the company well ahead of its crash on Tuesday (caused by a clinical trial failure for its lead drug to treat multiple sclerosis), which dropped its shares into penny stock territory. (fortune.com)
Bristol - Myers Squibb (bmy) shed about 16 % of its market value Friday after a clinical trial failure for one of its major cancer drugs sent investors fleeing. (fortune.com)
No. 1: Medical marijuana laws are passed, but GW Pharmaceuticals shares will continue to drop Admittedly, this is a new spin on my 2015 prediction that shares in marijuana drug developer GW Pharmaceuticals plc (NASDAQ: GWPH) would fall because of trial failures. (fool.com)